Weight-loss drugs may boost health in many ways
The first study to assess how weight-loss drugs affect the whole of human health has discovered an "eye-opening" impact on the body, researchers say. The analysis, involving about two million people,
Sweeping review suggests weight-loss drugs’ effect on 175 conditions
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected but contain surprises, too.
E-sellers of compounded weight-loss drugs fail to reveal risks, research shows
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do not inform patients of the risks associated with these medicines, according to a research letter published on Friday.
Weight-loss drugs reduce risk of Alzheimer’s, large study shows
Analysis of drugs such as Ozempic finds a lower health risk for 42 conditions but a higher rate of disorders such as arthritis
Popular weight-loss drugs linked to new health risks and benefits
Researchers have found links to multiple new benefits – and new side effects – in a study of weight-loss drugs such as Ozempic and Wegovy.
Novo Nordisk says its obesity drug in higher dose shows 20.7% weight loss
Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the results fell short of the weight loss achieved with Eli Lilly's rival drug Zepbound,
Tripling Wegovy dosage leads to more weight loss, Novo Nordisk trial shows
Tripling the dosage of the Wegovy weight-loss drug leads to more weight loss, Novo Nordisk said Friday. The Danish drugmaker announced results from a Phase 3B trial of semaglutide at a 7.2 milligram dosage,
Wegovy at Higher Dose Achieves Greater Weight Loss in Trial
Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, without experiencing an increase in side effects.
Novo Nordisk says higher Wegovy dose caused over 20% weight loss in late-stage trial
Novo Nordisk (NVO) announced Friday that a higher-dose version of its popular obesity therapy, semaglutide, marketed as Wegovy led to 20.7% weight loss over 72 weeks compared to 17.5% weight loss achieved by regular semaglutide in a late-stage trial.
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
6 Ways to Lose Weight Without Exercising This Year
There are plenty of tips on how to lose weight fast without exercise, from sketchy pills to crash diets that do more harm ...
Costco Employee Reveals the 16 Best Weight Loss Foods to Buy Right Now
A Costco employee reveals the 16 best foods for weight loss, from high-protein snacks to healthy meal essentials.
Fitness expert, who lost 35 kilos, advises excluding 10 foods for weight loss
Ansh Tripathi, a fitness expert, shares foods that hinder weight loss and offers healthier alternatives. Avoid sugary cereals ...
The Best High-Protein Breakfast for Weight Loss, Recommended by Dietitians
Eggs are probably top of mind when you think about adding more protein to your breakfast, but don’t forget about plant-based ...
The 10 Best Anti-Inflammatory Foods for Weight Loss, Ranked
Fight inflammation and shed pounds with these top 10 anti-inflammatory foods ranked by their weight-loss benefits.
Jessica Simpson’s 100-pound weight loss made her feel ‘21 again’ before split from husband Eric Johnson
She started to want to sow her wild oats in a way she never could,” a family source told Page Six of the singer feeling younger post-weight loss.
Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.